Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Treatment with Vitamin D/MOG Association Suppresses Experimental Autoimmune Encephalomyelitis.
Anti-idiotypic network induced by T cell vaccination against experimental autoimmune encephalomyelitis.
[Neurology at the border of centuries: achievements and prospects].
Teva Presents New Clinical Safety Data in RRMS Patients Treated with Laquinimod for Two or More Years at Joint ACTRIMS-ECTRIMS Meeting
[Consensus document on spasticity in patients with multiple sclerosis.]
Spin echo transverse relaxation and atrophy in multiple sclerosis deep gray matter: A two-year longitudinal study.
Role of a novel HLA-DQA1*01:02;DRB1*15:01 mixed-isotype heterodimer in the pathogenesis of 'humanized' multiple sclerosis-like disease.
Multiple sclerosis: individualized disease susceptibility and therapy response.
Examining Trait Mindfulness, Emotion Dysregulation, and Quality of Life in Multiple Sclerosis.
Erratum to: Guidelines on the clinical use for the detection of neutralizing antibodies (NAbs) to IFN beta in multiple sclerosis therapy: report from the Italian Multiple Sclerosis Study group.
Poster abstracts from the third international symposium on gait and balance in multiple sclerosis: selecting the right measures.
Breastfeeding and Disease-Modifying Therapy for Multiple Sclerosis-Reply.
Vitamin D supplementation, moderate sun exposure, and control of immune Diseases.
Murine K2P5.1 Deficiency Has No Impact on Autoimmune Neuroinflammation due to Compensatory K2P3.1- and KV1.3-Dependent Mechanisms.
Regulatory T cell proliferative potential is impaired in human autoimmune disease.
Effects of albendazole combined with TSII-A (a Chinese herb compound) on optic neuritis caused by Angiostrongylus cantonensis in BALB/c mice.
Genomic Binding Sites and Biological Effects of the Vitamin D: VDR Complex in Multiple Sclerosis.
Functional Cognitive Disorder: A Common Cause of Subjective Cognitive Symptoms.
The story of neuromyelitis optica continues to be written.
Cdk5 regulates developmental remodeling of mushroom body neurons in Drosophila.
Removal of access to alemtuzumab for patients with aggressive multiple sclerosis.
Matrine suppresses expression of adhesion molecules and chemokines as a mechanism underlying its therapeutic effect in CNS autoimmunity.
Aquaporin 4 antibody [NMO Ab] status in patients with severe optic neuritis in India.
Place of death, and its relation with underlying cause of death, in Parkinson's disease, motor neurone disease, and multiple sclerosis: A population-based study.
Interaction between passive smoking and two HLA genes with regard to multiple sclerosis risk.
Pages
« first
‹ previous
…
349
350
351
352
353
354
355
356
357
…
next ›
last »